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New simple and sensitive spectrophotometric and ﬂuorimetric methods have been developed and validated for the determination
of ﬂuoxetine hydrochloride (FLX) in its pharmaceutical formulations. The spectrophotometric method was based on the reaction
of FLX with 1,2-naphthoquinone-4-sulphonate (NQS) in an alkaline medium (pH 11) to form an orange-colored product that
was measured at 490 nm. The ﬂuorimetric method was based on the reaction of FLX with 4-chloro-7-nitrobenzo-2-oxa-1,3-
diazole (NBD-Cl) in an alkaline medium (pH 8) to form a highly ﬂuorescent product that was measured at 545nm after excitation
at 490nm. The variables aﬀecting the reactions of FLX with both NQS and NBD-Cl were carefully studied and optimized. The
kinetics of the reactions were investigated, and the reaction mechanisms were presented. Under the optimum reaction conditions,
good linear relationships were found between the readings and the concentrations of FLX in the ranges of 0.3–6 and 0.035–0.5μg
mL
−1 for the spectrophotometric and ﬂuorimetric methods, respectively. The limits of detection were 0.1 and 0.01μgm L
−1 for the
spectrophotometric and ﬂuorimetric methods, respectively. Both methods were successfully applied to the determination of FLX
in its pharmaceutical formulations.
Copyright © 2009 Ibrahim A. Darwish et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Fluoxetine (FLX); (3RS)-N-methyl-3-phenyl-3-[4-(triﬂuor-
omethyl)phenoxy] propane-1-amine hydrochloride is the
mostwidelyprescribedselectiveserotoninreuptakeinhibitor
antidepressant drug [1]. FLX is also uniquely eﬀective in
treatmentoftheobsessive-compulsivedisorders[2].Itiswell
absorbed after oral administration, and it takes 6–8 hours to
reachtheplasmapeak.Ithasalonghalf-lifetimethatallowed
for the introduction of once-weekly dosing. The resolution
of the adverse eﬀects after discontinuation of FLX is slow
[3]. These combined qualities made FLX the most widely
prescribed antidepressant drug worldwide.
FLX has been determined in its pharmaceutical for-
mulations by titrimetry [4], nuclear magnetic resonance
spectrometry [5], potentiometry [6], thin-layer chromatog-
raphy[7],liquidchromatography[4,7],gaschromatography
[8], and capillary electrophoresis [9]. These methods were
time-consuming, tedious, and/or dedicated to sophisticated
and expensive analytical instruments. Spectrophotometry
[10–12] and ﬂuorimetry [13–15] are the most convenient
techniques because of their inherent simplicity, high sen-
sitivity, low cost, and wide availability in quality control
laboratories. Unfortunately, the spectrophotometric [16–24]
and ﬂuorimetric [25–27] methods that have been reported
for determination of FLX in its pharmaceutical formulations
were associated with some major drawbacks such as the lack
of selectivity [16], tedious extraction procedures [20–24],
and time-consuming [17, 26]. Therefore, the development
of new alternative spectrophotometric and ﬂuorimetric
methods forthe determination of FLX that can overcome the
drawbacks of the existing methods was very essential.
1,2-Naphthoquinone-4-sulphonate (NQS) [28–30]a n d
4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) [31–33]
have been used as derivatizing reagents in the development
of both spectrophotometric and ﬂuorimetric methods for
determination of many pharmaceutical amines. FLX, being
amine, is a potential candidate for the reaction with both
NQS and NBD-Cl. The present study was devoted to
investigate the reaction of FLX with both reagents, and2 International Journal of Analytical Chemistry
employment the reactions in the development of new
simple spectrophotometric and ﬂuorimetric methods for the
determination of FLX in its pharmaceutical formulations.
2. Experimental
2.1.Apparatus. DoublebeamV-530(JASCOCo.Ltd.,Kyoto,
Japan) ultraviolet-visible spectrophotometer with matched
1-cm quartz cells was used for all the spectrophotometric
measurements. FP-6200 ﬂuorometer (JASCO Co. Ltd.), with
1-cm quartz cells, was used for the ﬂuorimetric measure-
ments. Also, pH meter, Model 350 (Bibby Scientiﬁc Ltd.,
T/As Jenway, Essex, England) and MLW type thermostati-
cally controlled water bath (Memmert GmbH, Co. Schwa
bach, Germany) were used.
2.2. Reagents and Materials. Fluoxetine hydrochloride (FLX;
Solvay Pharma, Suresnes, France) was obtained and used as
received; its purity was 99.5 ± 1.55%. A solution of 0.5%
(w/v) of 1,2-naphthoquinone-4-sulphonate (NQS; Aldrich
Chemical Co., St. Louis, USA) was prepared by dissolving
250mg in 50mL distilled water. The solution was freshly
prepared and protected from light during use. A solution
of 0.2% (w/v) of 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole
(NBD-Cl; Sigma Chemical Co., St. Louis, USA) was freshly
prepared by dissolving 100mg in 50mL acetone. Clark and
Lubs buﬀer solution was prepared by mixing 50mL of 0.2M
aqueous solution of boric acid and potassium chloride (1
liter contains 12.368 g of boric acid and 14.90 g of potassium
chloride)with21.3mLof0.2Msodiumhydroxidein200mL
standard ﬂask [34], and adjusted by pH meter. The following
pharmaceutical formulations were used: prozac (Eli Lilly
& Co. Ltd., Hampshire, UK), Fluzac (Riyadh Pharma,
Riyadh, Saudi Arabia), salipax (Mepha Ltd. Aesch-Basilea
Switzerland), ﬂutin (Egyptian International Pharmaceutical
Industries Co., Cairo, Egypt), and octozac (October Pharma,
Cairo, Egypt) capsules are labeled to contain 20mg FLX per
capsule. Double distilled water was obtained through WSC-
85 water puriﬁcation system (Hamilton Laboratory Glass
Ltd., Kent, USA) and used throughout the work. All solvents
and materials used throughout this study were of analytical
grade.
2.3. Preparation of Solutions
2.3.1.StandardFLXSolution. Anaccuratelyweighedamount
(50mg) of FLX was quantitatively transferred into a 25-mL
calibratedﬂask,dissolvedin20mLdistilledwater,completed
to volume with the same solvent to obtain a stock solution of
2mgmL
−1. The stock solution was found to be stable for at
least two weeks when kept in refrigerator. The stock solution
was further diluted with water to obtain working solutions
in the range of 3–60μgmL
−1 and 0.35–5μgmL
−1 for the
spectrophotometric and ﬂuorimetric methods, respectively.
2.3.2. Pharmaceutical Formulation Samples. The contents
of 20 capsules were weighed, and ﬁnely powdered. An
accurately weighed quantity of the powder equivalent to
100mg of the active ingredient was transferred into a
100-mL calibrated ﬂask, and dissolved in about 40mL of
distilled water. The contents of the ﬂask were swirled,
sonicated for 5 minutes, and then completed to volume with
water. The contents were mixed well and ﬁltered; the ﬁrst
portion of the ﬁltrate was rejected. The ﬁltered solution was
diluted quantitatively with distilled water to obtain suitable
concentrations for the analysis by the spectrophotometric
and ﬂuorimetric methods.
2.4. General Recommended Procedures
2.4.1. Spectrophotometric Method. One milliliter of FLX
solution containing 3–60μgmL
−1 was transferred into sep-
arate 10-mL calibrated ﬂask. One milliliter of Clark and Lubs
buﬀer solution of pH 11 was added followed by 1mL of NQS
solution (0.5%, w/v). The reaction solution was allowed to
proceed at room temperature (25±5◦C) for 10 minutes, and
completed to volume with methanol. The resulting solution
was measured at 490nm against reagent blank prepared in
the same manner with 1mL water instead of 1mL sample
solution.
2.4.2. Fluorimetric Method. One milliliter of FLX solution
containing 0.35–5μgmL
−1 was transferred into separate 10-
mL calibrated ﬂasks. One milliliter of Clark and Lubs buﬀer
solution of pH 8 ± 0.2 was added followed by 1mL of 0.2%
(w/v) NBD-Cl solution. The reaction mixture was allowed to
proceed in thermostatically controlled water bath at 70◦Cf o r
20minutes,andthencooledtoroomtemperature(25±5◦C).
After cooling, the reaction mixture was acidiﬁed by adding
1mL of 0.1M, and completed to volume with acetonitrile.
The relative ﬂuorescence intensity (RFI) of the resulting
solution was measured at λex = 490 nm, λem = 545 nm
against reagent blank prepared in the same manner with
1mL water instead of 1mL sample solution.
2.5. Determination of Stoichiometric Ratio. The limiting
logarithmic method [35] was employed. Two sets of experi-
ments were carried out employing the general recommended
procedures described above. The ﬁrst set of experiments
was carried using varying concentrations of the analytical
reagent with a ﬁxed concentration of FLX. The second set
of experiments was carried using varying concentrations of
FLX at a ﬁxed concentration of each reagent. The logarithms
of the obtained absorbances (for the reaction with NQS)
and RFI (for the reaction with NBD-Cl) were plotted as
a function of the logarithms of the concentrations of the
reagent and FLX in the ﬁrst and second sets of experiments,
respectively. The slopes of the ﬁtting lines in both sets of
experiments were calculated. The concentrations used in
these experiments were as follows.
2.5.1. Reaction with NQS. The ﬁrst set of experiments
was carried using varying concentrations of NQS (1.92 ×
10
−4–9.61 × 10
−4 M) at ﬁxed concentration of FLX (1.16 ×
10
−5 M). The second set of experiments was carried usingInternational Journal of Analytical Chemistry 3
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Figure 1: Absorption spectra of FLX (100μgmL
−1) against water
(1) and its reaction product with NQS (0.5%, w/v) against reagent
blank (2).
varying concentrations of FLX (4.60 × 10
−7–1.53 × 10
−5 M)
at a ﬁxed concentration of NQS (1.92 ×10
−3 M).
2.5.2. Reaction with NBD-Cl. The ﬁrst set of experiments
was carried using varying concentrations of NBD-Cl (5 ×
10
−5–5 × 10
−4 M) at ﬁxed concentration of FLX (5.78 ×
10
−7 M). The second set of experiments was carried using
varying concentrations of FLX (5.78 × 10
−8–6.94 × 10
−7 M)
at a ﬁxed concentration of NBD-Cl (1 ×10
−3 M).
3. Results andDiscussion
3.1. Absorption and Fluorescence Spectra. The absorption
spectrum of FLX was recorded against water (Figure 1). It
was found that the maximum absorption peak (λmax)o f
FLX was 260 nm, and its molar absorptivity (ε)w a s1 .3 ×
104 lmol
−1cm−1. Because of the highly blue shifted λmax of
FLX, its determination in the pharmaceutical formulations
based on the direct measurement of its absorption for
ultraviolet light is susceptible to potential interferences from
the coextracted common excipients. As well, the low ε
value could ultimately result in poor sensitivity. Therefore,
derivatization of FLX to more red-shifted light-absorbing
derivative was necessary. The reaction between FLX and
NQS was performed, and the absorption spectrum of the
product was recorded against reagent blank. The product
was orange-colored exhibiting λmax at 490nm (Figure 1).
Obviously, the λmax of FLX-NQS derivative was red-shifted
by 230 nm. This high red shift could ultimately eliminate
any potential interference. As well, the value of ε (sensitivity)
wasgreatlyenhancedto be 4.8×104 lmol
−1cm−1. Therefore,
the spectrophotometric measurements were carried out at
490nm.
FLX does not have a native ﬂuorescence, thus its
derivatization with ﬂuorogenic reagent was necessary for
its ﬂuorimetric determination. NBD-Cl forms highly ﬂu-
orescent derivative with secondary amines using relatively
mild reaction conditions [31–33]; therefore, it was chosen
as a derivatizing reagent for FLX. Owing to the presence
of labile chloride in the chemical structure of NBD-Cl, a
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Figure 2: Excitation (1) and emission (2) spectra of FLX
(0.03μgmL
−1) and its reaction product with NBD-Cl (0.2%, w/v)
against reagent blank.
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Figure 3: Eﬀe c to fN Q S( •) and NBD-Cl (◦) concentrations
on their reaction with FLX. FLX concentrations were 3 and
0.02μgmL
−1 for its reaction with NQS and NBD-Cl, respectively.
RFI is the relative ﬂuorescence intensity.
daily fresh solution was prepared and tested in the present
study. It was found that FLX reacts with NBD-Cl and
forms yellow-colored ﬂuorescent derivative. This derivative
exhibited maximum ﬂuorescence intensity (λem) at 545nm
after its excitation at wavelength (λex) of 490nm. The
excitation and emission spectra for the reaction product of
FLX with NBD-Cl are given in Figure 2.
3.2. Optimization of Reaction Variables
3.2.1. Eﬀect of Reagent Concentration. The eﬀect of NQS
and NBD-Cl concentrations on their reactions with FLX
revealed that the reactions were dependent on the reagent
concentration as the readings increased with the increase in
the reagent concentration (Figure 3). The highest readings
were attained at concentration ranges of 0.25–1 and 0.1–
0.4% (w/v) for NQS and NBD-Cl, respectively. For high
precisevalues,furtherexperimentswerecarriedoutusing0.5
and 0.2% for NQS and NBD-Cl, respectively.
3.2.2. Eﬀect of pH. The inﬂuence of pH on the reaction
of FLX with both NQS and NBD-Cl was investigated by4 International Journal of Analytical Chemistry
Table 1: Summary for the optimization of variables aﬀecting the reaction of FLX with NQS and NBD-Cl reagents employed in the
development of the proposed spectrophotometric and ﬂuorimetric methods, respectively.
Variable Spectrophotometric method Fluorimetric method
Studied range Optimum Studied range Optimum
NQS (%, w/v) 0.05–0.8 0.5
NBD-Cl (%, w/v) 0.01–0.5 0.2
pH 6–13 11 5–9.5 8 ± 0.2
Temperature (◦C) 25–90 25 25–70 70
T i m e ( m i n u t e s ) 2 – 2 51 05 – 6 0 2 0
Diluting solvent Diﬀerent(a) Methanol Diﬀerent(a) Methanol(b)
Measuring wavelength (nm) 400–600 490 400–600 490 (λex), 545 (λem)
(a)Solventstested:methanol,ethanol,isopropanol,acetone,acetonitrile,dimethylsulphoxide,and1,4-dioxane. (b)Onemilliliterof0.1MHClwasaddedbefore
dilution with methanol.
Table 2: Analytical parameters for the proposed spectrophotometric and ﬂuorimetric methods for determination of FLX based on its
reaction with NQS and NBD-Cl, respectively.
Parameter Spectrophotometric Fluorimetric
method method
Linear range (μgmL
−1) 0.3–6 0.035–0.5
Intercept 0.0006 2.1766
SD of intercept 0.0038 1.9249
Slope 0.1356 0.5793
SD of slope 0.0014 0.0084
Correlation coeﬃcient 0.9997 0.9992
LOD (μgmL
−1) 0.1 0.011
LOQ ((μgmL
−1) 0.3 0.033
Table 3: Replicate analysis of FLX solution by the proposed spec-
trophotometric and ﬂuorimetric methods.
Sample number Absorbance RFI
(FLX = 3μgmL
−1)( F L X = 0.2μgmL
−1)
1 0.453 120
2 0.458 110
3 0.451 117
4 0.471 115
5 0.459 121
Mean 0.458 116.6
SD 0.007 3.93
RSD 1.52 3.37
carrying out the reaction in buﬀer solution of varying pH
values. The results revealed that FLX has diﬃculty to react
with both NQS and NBD-Cl in acidic media (Figure 4).
This was possibly due to the existence of the amino group
of FLX in the form of hydrochloride salt, thus it loses its
nucleophilic substitution capability. As the pH increased,
the readings increased rapidly, as the amino group of FLX
(in the hydrochloride salt) turns into the free amino group,
thusfacilitatingthenucleophilicsubstitution.Themaximum
readings were attained at pH values of 11 and 8 for the
reaction with NQS and NBD-Cl, respectively. At higher
pH values, sharp decrease in the readings occurred. This
was attributed probably to the increase in the amount of
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Figure 4: Eﬀe c to fp Ho nt h er e a c t i o no fF L Xw i t hN Q S( 0 . 5 % ,
w/v) and NBD-Cl (0.2%, w/v). FLX concentrations were 3 and
0.02μgmL
−1 for its reaction with NQS and NBD-Cl, respectively.
RFI is the relative ﬂuorescence intensity.
hydroxide ion that holds back the reaction of FLX with NQS
and NBD-Cl.
3.2.3. Eﬀect of Temperature and Time. The eﬀect of tempera-
ture on the reaction was studied by carrying out the reaction
at diﬀerent temperatures (25–90◦C). It was found that the
reaction of FLX with NQS was not aﬀected by increasing the
temperature, and the reaction at room temperature (25 ±
5◦C) went to completion in 10 minutes, and longer reactionInternational Journal of Analytical Chemistry 5
Table 4: Recovery studies for determination of FLX by the proposed spectrophotometric and ﬂuorimetric methods.
Spectrophotometric method Fluorimetric method
Added (μgmL
−1)R e c o v e r y ( % ± SD)(a) Added (μgmL
−1)R e c o v e r y ( % ± SD)(a)
2.0 98.8 ±0.60 .10 97.5 ±2.1
3.0 99.5 ±1.00 .15 98.1 ±1.9
4.0 101.5 ±1.20 .20 100.2 ±2.2
5.0 102.0 ±1.00 .25 99.6 ±1.5
6.0 99.0 ±0.80 .30 100.2 ±1.9
(a)Values are mean of three determinations.
Table 5: Analysis of FLX in presence of common excipients by the
proposed spectrophotometric and ﬂuorimetric methods.
Excipient
Recovery (%± SD)(a)
Spectrophotometric Fluorimetric
method method
Starch (50)(b) 99.6 ±0.8 101.0 ±2.2
Glucose (10) 100.1 ±1.09 8 .7 ±2.1
Lactose (10) 99.8 ±0.59 9 .6 ±1.9
Acacia (10) 100.2 ±0.99 8 .7 ±1.4
Talc (5) 99.6 ±1.09 9 .4 ±1.3
MS(c) (10) 100.1 ±0.19 7 .0 ±2.8
Average ± SD 99.9 ±0.49 9 .1 ±1.3
(a)Values are mean of three determinations. (b)Figures in parenthesis are the
amounts in mg added to 20mg of FLX. (c)MS = Magnesium stearate.
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Figure 5: Eﬀect of temperature (•) and time (◦) on the reaction of
FLX (3μgmL
−1) with NQS (0.5%, w/v).
time up to 25 minutes did not aﬀect the reaction (Figure 5).
Therefore, further experiments involving NQS reagent were
c a r r i e do u ta tr o o mt e m p e r a t u r e( 2 5±5◦C) for 10 minutes.
The reaction of FLX with NBD-Cl at room temperature
(25 ± 5◦C) was found to be very slow, as it required more
than 1 hour for completion (Figure 6). Therefore, the reac-
tion was carried out at varying elevated temperatures (40–
70◦C) for varying times, and the intensities of the induced
ﬂuorescence were measured. The optimum conditions were
considered as the conditions at which high RFI values, high
reproducible results, and comfortable measurements (wide
0
40
80
120
160
R
F
I
0 1 02 03 04 05 06 07 0
25◦C
40◦C
50◦C
60◦C
70◦C
Time (min)
Figure 6: Eﬀect of time on the reaction of FLX (0.02μgmL
−1) with
NBD-Cl (0.2%, w/v) at diﬀerent temperatures. RFI is the relative
ﬂuorescence intensity.
plateau region on the RFI-time curve) could be obtained.
The results indicated that the reaction was dependent on
temperature, and the optimum conditions were achieved by
heating the reaction at 70◦Cf o r2 0m i n u t e s( Figure 6).
3.2.4. Eﬀect of Diluting Solvent. Upon diluting the reaction
solutions with water, colloids were obtained indicating the
incomplete solubility of FLX-NQS and FLX-NBD derivatives
in water. Therefore, water could not be used for dilution.
In order to select the most appropriate organic solvent
for diluting the reaction solutions, diﬀerent solvents were
tested: methanol, ethanol, isopropanol, acetone, acetonitrile,
dimethylsulphoxide, and 1,4-dioxane. The highest readings
were obtained when methanol was used for dilution. With
NBD-Cl, signiﬁcantly high ﬂuorescence background was
observed. This was attributed to the hydrolysis of NBD-
Cl to the corresponding hydroxy derivative, namely, 4-
hydroxy-7-nitrobenzo-2-oxa-1,3-diazole (NBD-OH) [36].
The ﬂuorescence of NBD-OH was found to be quenched
by decreasing the pH of the reaction medium to less than
one [37]. Therefore acidiﬁcation of the reaction mixture
prior to dilution and measurement of the RFI was neces-
sary to remarkably decrease the background ﬂuorescence.
Meanwhile, the reaction product was not aﬀected, thus the
sensitivity was ultimately enhanced. It was found that the6 International Journal of Analytical Chemistry
Table 6: Determination of FLX in its pharmaceutical formulations (capsules) by the proposed spectrophotometric, ﬂuorimetric and the
oﬃcial methods.
Capsules Spectrophotometric method Fluorimetric method
Recovery (%) ± SD(a) F value(b) t value(b) Recovery (%) ± SD(a) F value(b) t value(b)
Prozac 99.9 ±1.4 1.68 1.17 99.7 ±1.6 2.38 3.00
Pluzac 100.1 ±1.3 2.62 1.27 99.2 ±1.5 1.58 2.91
Salipax 99.8 ±1.3 1.00 1.10 100.8 ±1.8 1.60 2.18
Flutin 100.1 ±1.6 1.64 1.27 100.1 ±1.3 0.19 1.12
Octozac 99.8 ±1.2 2.35 2.13 99.4 ±1.5 1.49 2.47
(a)Values are mean of ﬁve determinations ± SD. (b)Theoretical values for t and F at 95% conﬁdence limit (n = 5) were 2.78 and 6.39, respectively.
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Figure 7: Limiting logarithmic plots for molar reactivity of FLX
with NQS (a) and NBD-Cl (b). C, A, and RFI are the concentration,
absorbance, and relative ﬂuorescence intensity, respectively.
concentration of HCl required for acidiﬁcation was 0.01M
in the ﬁnal assay solutions (i.e., 1mL of 0.1M).
3.2.5. Stability of the Chromophore and Fluorophore. After
dilution the reaction solutions, it was found that the
absorbance of the chromogen (FLX-NQS) and the FI of the
ﬂuorophore (FLX-NBD) remained stable for at least 4 hours.
This allowed the processing of large batches of samples,
and their comfortable measurements with convenience. This
increasedtheconvenienceofthemethods aswellasmadethe
method applicable for large number of samples.
3.3. Stoichiometry and Kinetics of the Reactions. Under
the optimum conditions (Table 1), the stoichiometries of
the reaction of FLX with both NQS and NBD-Cl were
investigatedbythelimitinglogarithmicmethod[35].Ineach
case, two straight lines were obtained (Figure 7). The slopes
of these lines were comparable conﬁrming the 1 : 1 ratio for
the reactions. Based on this ratio, the reaction pathways were
postulated to be proceeded as shown in Figure 8.
Under the optimum conditions, the signal-time curves
for the reactions at varying concentrations of FLX (1.1 ×
10
−6–1.6×10
−5 and2.3×10
−6–9.2×10
−6 Mforthereactions
with NQS and NBD-Cl, resp.) with a ﬁxed concentration of
NQS (1.92 × 10
−3 M) and NBD-Cl (1 × 10
−3 M) were gen-
erated. The initial reaction rates (K) were determined from
the slopes of these curves. The logarithms of the reaction
rates(LogK) were plotted as a function of logarithms of FLX
concentrations (log C). Straight lines with slope values of
0.9708(withNQS)and0.8378(withNBD-Cl)wereobtained
by ﬁtting the data to the following equation:
LogK = log K
  + n log C,( 1 )
where K is reaction rate, K  is the rate constant, C is the
molar concentration of FLX, and n (slope of regression line)
is the order of the reaction. The values of the slopes (≈1)
conﬁrmed that the reactions were ﬁrst order. However under
the optimized reaction conditions, the concentrations of
NQS and NBD-Cl were in much more excess than that of
FLX in the reaction solution. Therefore, the reactions were
regarded as pseudo-ﬁrst order reactions.
3.4. The Apparent Rate Constant and Activation Energy.
As the reaction of FLX with NQS was not aﬀected by
the temperature, therefore, it was ruled out from this
investigation. The RFI-time curves for the reaction of FLX
with NBD-Cl were generated by carrying out the reaction
at diﬀerent temperatures (25, 40, 50, 60, and 70◦C) using
ﬁxed concentration of FLX (4.3×10
−7 M), and NBD-Cl (1×
10
−3 M). From these curves, the apparent rate constant was
calculated. The activation energy, deﬁned as the minimum
kinetic energy that a molecule possess in order to undergo a
reaction, was determined using Arrhenius equation [38]:
Logk = log A −
Ea
2.303
RT,( 2 )
where k is the apparent rate constant, A is the frequency fac-
tor, Ea is the activation energy, T is the absolute temperature,
and R is the gas constant (1.987cal degree
−1mole
−1). The
values of log k were plotted as a function of 1/T. Straight lineInternational Journal of Analytical Chemistry 7
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with slope (= −Ea/2.303 R)v a l u e so f−1.4598 was obtained
(Figure 9). The activation energy was calculated and found
to be 6.68kcal mole
−1. This low activation energy explains
that the reaction of FLX with NBD-Cl could easily take place
undermildconditions,andNBD-Clcouldbeusedasauseful
analytical reagent in the ﬂuorimetric determination of FLX.
3.5. Validation of the Methods
3.5.1. Linearity, Limits of Detection. In the proposed meth-
ods, linear plots (n = 5) with good correlation coeﬃ-
cients were obtained in the concentration ranges of 0.3–
6 and 0.035–0.5μgmL
−1 for the spectrophotometric and
ﬂuorometric methods, respectively (Table 2). The limits of
detection (LOD) and quantitation (LOQ) were determined
[39] using the formula: LOD or LOQ = κSDa/b, where κ =
3.3forLODand10forLOQ,SDaisthestandarddeviationof
theintercept,andbistheslope.TheLODvalueswere0.1and
0.011μgmL
−1 and LOQ were 0.3 and 0.033μgmL
−1, for the
spectrophotometric and ﬂuorimetric methods, respectively
(Table 2).
3.5.2. Reproducibility. The reproducibility of the proposed
methods was determined by replicate analysis of ﬁve sep-
arate solutions of the working standards. The methods
gave satisfactory results; the relative standard deviations
(RSDs) were 1.52 and 3.37% for the spectrophotometric and
ﬂuorimetric methods, respectively (Table 3), indicating good
reproducibilityoftheproposedmethods.Thisprecisionlevel
is adequate for the precision and routine analysis of FLX in
quality control laboratories.
3.5.3. Accuracy and Speciﬁcity. The accuracy of the proposed
methods was evaluated by the recovery studies for added
concentrations of FLX. The recovery values were 98.8 ±
0.6–102.0 ± 1.0a n d9 7 .5 ± 2.1–100.2 ± 2.2% for the
spectrophotometric and ﬂuorimetric methods, respectively
(Table 4), indicating the accuracy of the proposed methods.
The speciﬁcity of the methods was evaluated by investigating
the interference liabilities from the common excipients that
mightbeaddedduringpharmaceuticalformulation.Samples
were prepared by mixing known amount (20mg) of FLX
with various amounts of the common excipients: starch,
glucose, lactose, acacia, talc, and magnesium stearate. These
laboratory-prepared samples were analyzed by the proposed
methods applying the general recommended procedure.
The average recovery values were 99.9 ± 0.4a n d9 9 .1 ±
1.3% for the spectrophotometric and ﬂuorimetric methods,
respectively (Table 5). These data conﬁrmed the absence of
interference from any of the common excipients with the
determination of FLX by both methods.8 International Journal of Analytical Chemistry
3.5.4. Robustness and Ruggedness. Robustness was examined
by evaluating the inﬂuence of small variation in the method
variablesonitsanalyticalperformance.Intheseexperiments,
one parameter was changed whereas the others were kept
unchanged, and the recovery percentage was calculated each
time. It was found that small variation in the method
variables did not signiﬁcantly aﬀect the procedures; recovery
values were 97.5–100.5 ± 1.3–1.9%. The most critical factor
aﬀecting the results was the pH that should be adjusted to be
in the range of optimum ±0.2. Ruggedness was also tested
by applying the methods to the assay of FLX using the same
operationalconditionsbutusingtwodiﬀerentinstrumentsat
two diﬀerent laboratories and diﬀerent elapsed time. Results
obtained from lab-to-lab and day-to-day variations were
reproducible, as the RSD did not exceed 4%.
3.6.ApplicationsoftheMethods. Itisevidentfromtheabove-
mentioned results that the proposed methods gave satisfac-
tory results with FLX in its bulk. Thus its pharmaceutical
formulations were subjected to the analysis of their FLX
contents by the proposed and the oﬃcial [16] methods. The
label claim percentages were 99.8 ± 1.2–100.1 ± 1.6a n d
99.2 ± 1.5–100.8 ± 1.8% for the spectrophotometric and
ﬂuorimetric methods, respectively (Table 6). These results
were compared with those obtained from the oﬃcial method
by statistical analysis with respect to the accuracy (by t-test)
and precision (by F-test). No signiﬁcant diﬀerences were
found between the calculated and theoretical values of t-a n d
F-tests at 95% conﬁdence level proving similar accuracy and
precision in the determination of FLX by both methods.
4. Conclusions
The present paper described the evaluation of NQS and
NBD-Cl as analytical reagents in the development of simple,
sensitive, and accurate spectrophotometric and ﬂuorimetric
methods, respectively, for the determination of FLX in bulk
and pharmaceutical formulations. The described methods
are superior to the previously reported spectrophotometric
or ﬂuorimetric methods in terms of the simplicity and sen-
sitivity. The proposed methods have comparable analytical
performances and devoid from any potential interference.
This gives the advantage of ﬂexibility in performing the anal-
ysis on any available instrument. Therefore, these methods
can be recommended for the routine analysis of FLX in
quality control and clinical laboratories.
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